Xeraya Capital has completed funding of a total of USD15 million into ViewRay Incorporated (“ViewRay”), a medical device manufacturer in February 2015. ViewRay was founded in 2004 and is focused on the development of a potentially disruptive real-time magnetic resonance imaging (MRI) guided radiation therapy device for the treatment of cancer patients